Milestone note Mar 2026
World's first commercial invasive-BCI approval
Reached
Neuracle / NMPA (China) — China's NMPA cleared Neuracle's coin-sized NEO implant (developed with Tsinghua) for commercial sale to restore hand function after spinal-cord injury — the first invasive-class BCI approved for market anywhere, ahead of Neuralink.